Baillie Gifford & Co
MDXG icon

Baillie Gifford & Co’s MiMedx Group MDXG Stock Holding History

Baillie Gifford & Co’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-513
Closed -$5K – 478
2021
Q1 		$5K Buy
513
+29
+6% +$280 ﹤0.01% 435
2020
Q4 		$4K Buy
+484
New +$3.48K ﹤0.01% 420

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Baillie Gifford & Co's MDXG Position: Q2 2021 in Review

Baillie Gifford & Co sold out of MiMedx Group (MDXG) in Q2 2021, closing a stake of 513 shares — an estimated $5K sold.

Baillie Gifford & Co first reported a position in MDXG in Q4 2020 and held it in 2 quarters. The position peaked at $5K in Q1 2021. 138 funds tracked by Wall St. Rank hold MDXG as of Q2 2021.

  • Baillie Gifford & Co reported no remaining MiMedx Group position as of Q2 2021 after selling out during the quarter.
  • Baillie Gifford & Co sold 513 MiMedx Group shares in Q2 2021, an estimated $5K.
  • Baillie Gifford & Co first reported a position in MiMedx Group in Q4 2020 and held it in 2 quarters.
  • Baillie Gifford & Co's MiMedx Group position peaked at $5K in Q1 2021.
  • 138 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2021.

Based on Baillie Gifford & Co's 13F filing for Q2 2021, filed 2 Aug 2021.